Publications

DLBCL 1L—What to Expect beyond R-CHOP?

View External Link

Recent updates on the role of extracellular vesicles in the pathogenesis of allergic asthma

Sundar, S. A., et al. Recent updates on the role of extracellular vesicles in the pathogenesis of allergic asthma. Extracell Vesicles Circ Nucleic Acids 2021;2:127-47 DOI: 10.20517/evcna.2021.03

Download pdf 1.3MB

Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis

Precazzini, F. et al. Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis. Int. J. Mol. Sci. 2021, 22(3), 1176; https://doi.org/10.3390/ijms22031176

Download pdf 2.6MB

BIRC3 and BIRC5: multi-faceted inhibitors in cancer

Frazzi, Raffael. BIRC3 and BIRC5: multi-faceted inhibitors in cancer. Cell & Bioscience 11, Article number: 8(2021)

Download pdf 2.2MB

A review of the use of Next Generation Sequencing methodologies to identify biomarkers of resistance to CKK4/6 inhibitors in ER+/HER2-breast cancer

Servetto, A., et al. A review of the use of Next Generation Sequencing methodologies to identify biomarkers of resistance to CKK4/6 inhibitors in ER+/HER2-breast cancer. Science Direct December 2020 DEC 9, 103191

Download pdf 3.4MB

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine

Lodhi, N., et al. Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine. Oncotarget 2020(11):44, 4055-4073. 

Download pdf 3.6MB

Biomarkers in Anderson–Fabry Disease

Simonetta, I., et al. Biomarkers in Anderson–Fabry Disease. International Journal of Molecular Sciences. 2020,21,8080;doi:10.3390/ijms21218080

Download pdf 1.5MB

Molecular, genomic and mutational landscape of oral leukoplakia

Farah, C. S. Molecular, genomic and mutational landscape of oral leukoplakia. Oral Diseases. 2020 AUG 3. DOI: 10.1111/odi.13608

View External Link

Cyclins E1 and E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets

Milioli, H., et al. Cyclins E1 and E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets. Bioscientifica 2020:27(5) R93-R112. DOI: https://doi.org/10.1530/ERC-19-0501

View External Link

Circulating microRNAs as Potential Biomarkers for Monitoring the Response to In Vivo Treatment With Rituximab in Systemic Lupus Erythematosus Patients

Cecchi, I., et al. Circulating microRNAs as Potential Biomarkers for Monitoring the Response to In Vivo Treatment With Rituximab in Systemic Lupus Erythematosus Patients. Autoimmunity Reviews 2020; 9(202) article 102488 In Press

Download pdf 929KB

The Extracellular RNA communication Consortium: establishing Foundational Knowledge and Technologies for Extracellular RNA Research

Saumya, D., et al. The Extracellular RNA communication Consortium: establishing Foundational Knowledge and Technologies for Extracellular RNA Research. Cell 2019; 177: 231-242

Download pdf 625KB

Possibilities of Liquid Biopsy in Clinical Practice

Perisa J., et al. Possibilities of Liquid Biopsy in Clinical Practice. Libri Oncol. 2017;45(1):23-30.

Download pdf 290KB